The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides Lack Reliable Safety Information, Watchdog Warns Mitigating Risks of Compounded Drugs Through Surveillance FDA Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law